Analyst Consensus ?
ConsensusBuy32 ratings
Bullish2475.0%
Neutral825.0%
Bearish00.0%
Marathon Petroleum Corporation · MPC · FY2026 Q3 · Calendar Q4 2026
MPC posts record Q3 utilization and EBITDA, plans Gulf Coast reinvestment
Record refinery utilization and $11.7 billion of adjusted EBITDA, together with proceeds from refinery sales earmarked for Gulf Coast projects and continued midstream expansion, support a constructive operating picture. That case remains sensitive to margin volatility, Q4 turnaround costs, geopolitical supply disruptions and capital-allocation choices.
Reported Before market openNYSEEnergy
$120.86B market cap
80quality score
Earnings scorecard
Reported versus consensus
Reported EPS
—
Consensus $25.37
EPS surprise
—
Reported versus consensus
Reported revenue
—
Consensus $46.60B
Revenue surprise
—
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
-0.7%
Event window
SPY move
+0.3%
Same window
Abnormal move
-1.0%
Stock minus SPY
Volume
1.3×
Versus trailing sessions
Subsequent drift
0.0%
Up to 20 sessions
MPCSPY benchmark
Ask FN2 about MPC FY2026 Q3
Transcript, numbers and history already loaded
What drove MPC's -0.7% move after FY2026 Q3 earnings?What changed in MPC's guidance and outlook in FY2026 Q3?Give me the bull and bear case for MPC after FY2026 Q3 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
The supplied Q3 analysis describes record 100% refinery utilization across all regions and $11.7 billion of adjusted EBITDA. It also adds the announced sale of the Saint Paul Park and Mandan refineries, with $3.4 billion received by MPC, and plans to redeploy proceeds into Gulf Coast projects. The prior-quarter analysis described 94% overall utilization and $8.5 billion of adjusted EBITDA.
Guidance delta
Guidance sentiment was described as maintained. Management remained constructive on refining margins through mid-cycle 2027 and targeted 95% refinery utilization in Q4, with planned turnarounds.
Key takeaways
- Management reported record 100% refinery utilization across all regions in Q3 and $11.7 billion of adjusted EBITDA.
- MPC plans to redeploy refinery-sale proceeds into Gulf Coast projects, including a 90 kbpd distillate treater and Garyville feedstock upgrades.
- MPLX growth priorities include the Solitude Pipeline and Titan expansion; the analysis also notes increased distributions.
- Management cited wider Western Canadian crude differentials and expected record heavy Canadian processing in Q4.
Management priorities
- Redeploy refinery-sale proceeds into Gulf Coast growth projects.
- Bring additional midstream assets online, including Solitude Pipeline and Titan expansion.
- Target 95% refinery utilization in Q4 while managing planned turnarounds.
- Continue dividend growth and share repurchases.
Follow MPC with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$427.34Current
$68Low
$267.11Average
$560High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 3, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| TD Cowen | Buy | Buy | Maintain | Oct 22, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Oct 14, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Oct 13, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Oct 12, 2026 |
| Barclays | Overweight | Overweight | Maintain | Oct 12, 2026 |
| Mizuho | Neutral | Neutral | Maintain | Oct 8, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Oct 2, 2026 |
| Jefferies | Hold | Buy | Downgrade | Sep 22, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Sep 21, 2026 |
| Raymond James | Outperform | Outperform | Maintain | Sep 14, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Sep 14, 2026 |
| UBS | Buy | Buy | Maintain | Sep 8, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Sep 3, 2026 |
| Scotiabank | Sector Outperform | Sector Outperform | Maintain | Apr 22, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Feb 9, 2026 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Jul 14, 2025 |
| JP Morgan | Neutral | Neutral | Maintain | Oct 9, 2024 |
| RBC Capital | Outperform | Outperform | Maintain | Aug 2, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Feb 1, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | May 4, 2022 |
| Macquarie | Outperform | Outperform | Maintain | Feb 6, 2019 |
| Standpoint Research | Buy | Accumulate | Maintain | Dec 26, 2018 |
| Bank of America | Buy | Neutral | Upgrade | May 10, 2018 |
| Deutsche Bank | Buy | Buy | Maintain | Mar 19, 2018 |
| PiperJaffray | Neutral | Neutral | Maintain | Sep 16, 2016 |
| Scotia Howard Weil | Sector Outperform | Sector Perform | Upgrade | Dec 15, 2015 |
| Oppenheimer | Outperform | Perform | Upgrade | May 27, 2015 |
| S&P Capital IQ | Buy | Hold | Upgrade | Jul 3, 2014 |
| Imperial Capital | Outperform | In Line | Upgrade | Jan 31, 2014 |
| ISI Group | Buy | Neutral | Upgrade | Jan 30, 2014 |
| Simmons & Co. | Overweight | Neutral | Upgrade | Dec 2, 2013 |
| Tudor Pickering | Buy | Buy | Maintain | Jul 23, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $427.34. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Wells Fargo | Analyst unavailable | $560 | $476.98 | +31.0% | Oct 14, 2026 |
| Jefferies | Lloyd Byrne | $433 | $455.03 | +1.3% | Oct 11, 2026 |
| UBS | Manav Gupta | $510 | $468.02 | +19.3% | Oct 9, 2026 |
| Mizuho Securities | Nitin Kumar | $457 | $442.26 | +6.9% | Oct 8, 2026 |
| Jefferies | Lloyd Byrne | $413 | $402.38 | -3.4% | Sep 21, 2026 |
| Goldman Sachs | Analyst unavailable | $472 | $424.89 | +10.5% | Sep 21, 2026 |
| Raymond James | Analyst unavailable | $445 | $404.77 | +4.1% | Sep 14, 2026 |
| Morgan Stanley | Joe Laetsch | $453 | $407.14 | +6.0% | Sep 14, 2026 |
| UBS | Analyst unavailable | $450 | $388.9 | +5.3% | Sep 8, 2026 |
| Piper Sandler | John Royall | $462 | $387 | +8.1% | Sep 3, 2026 |
| Wells Fargo | Analyst unavailable | $400 | $373.32 | -6.4% | Sep 1, 2026 |
| Mizuho Securities | Analyst unavailable | $304 | $320.32 | -28.9% | Aug 11, 2026 |
| Piper Sandler | John Royall | $344 | $300.09 | -19.5% | Aug 6, 2026 |
| Barclays | Analyst unavailable | $321 | $297.75 | -24.9% | Aug 6, 2026 |
| Evercore ISI | Analyst unavailable | $330 | $310.71 | -22.8% | Aug 5, 2026 |
| Wells Fargo | Analyst unavailable | $359 | $312.61 | -16.0% | Aug 5, 2026 |
| Piper Sandler | Analyst unavailable | $343 | $315.82 | -19.7% | Jul 23, 2026 |
| Raymond James | Justin Jenkins | $335 | $294.06 | -21.6% | Jul 13, 2026 |
| Barclays | Analyst unavailable | $289 | $283.74 | -32.4% | Jul 13, 2026 |
| Jefferies | Analyst unavailable | $335 | $283.74 | -21.6% | Jul 12, 2026 |
| UBS | Manav Gupta | $321 | $280.61 | -24.9% | Jul 10, 2026 |
| Wells Fargo | Sam Margolin | $344 | $263.58 | -19.5% | Jun 15, 2026 |
| Morgan Stanley | Analyst unavailable | $265 | $260.81 | -38.0% | Jun 12, 2026 |
| Mizuho Securities | Analyst unavailable | $284 | $248.05 | -33.5% | May 27, 2026 |
| UBS | Analyst unavailable | $285 | $249.32 | -33.3% | May 6, 2026 |
| Barclays | Analyst unavailable | $270 | $260.51 | -36.8% | May 6, 2026 |
| Morgan Stanley | Joe Laetsch | $233 | $221.1 | -45.5% | Apr 24, 2026 |
| Barclays | Analyst unavailable | $230 | $220.27 | -46.2% | Apr 10, 2026 |
| Piper Sandler | Analyst unavailable | $228 | $223.52 | -46.6% | Apr 9, 2026 |
| BMO Capital | Phillip Jungwirth | $225 | $203.91 | -47.3% | Feb 9, 2026 |
| UBS | Manav Gupta | $221 | $203.63 | -48.3% | Feb 6, 2026 |
| Wells Fargo | Analyst unavailable | $217 | $187.58 | -49.2% | Feb 4, 2026 |
| Scotiabank | Paul Cheng | $174 | $176.1 | -59.3% | Jan 16, 2026 |
| Mizuho Securities | Analyst unavailable | $205 | $175.54 | -52.0% | Jan 13, 2026 |
| Piper Sandler | Analyst unavailable | $184 | $172.51 | -56.9% | Jan 8, 2026 |
| Mizuho Securities | Analyst unavailable | $196 | $186.97 | -54.1% | Dec 12, 2025 |
| Raymond James | Justin Jenkins | $200 | $184.54 | -53.2% | Nov 4, 2025 |
| Raymond James | Justin Jenkins | $203 | $181.15 | -52.5% | Oct 17, 2025 |
| Barclays | Theresa Chen | $194 | $180.89 | -54.6% | Oct 13, 2025 |
| Scotiabank | Analyst unavailable | $189 | $189.06 | -55.8% | Oct 9, 2025 |
| Morgan Stanley | Analyst unavailable | $200 | $192.24 | -53.2% | Oct 3, 2025 |
| UBS | Analyst unavailable | $220 | $196.44 | -48.5% | Sep 26, 2025 |
| Evercore ISI | Stephen Richardson | $170 | $167.42 | -60.2% | Jun 18, 2025 |
| Raymond James | Analyst unavailable | $193 | $147.35 | -54.8% | Mar 27, 2025 |
| Barclays | Analyst unavailable | $161 | $141.15 | -62.3% | Mar 14, 2025 |
| Morgan Stanley | Joe Laetsch | $174 | $151.06 | -59.3% | Dec 19, 2024 |
| Bank of America Securities | Jean Ann Salisbury | $174 | $157.9 | -59.3% | Oct 17, 2024 |
| Scotiabank | Paul Cheng | $170 | $162.61 | -60.2% | Oct 10, 2024 |
| Piper Sandler | Ryan Todd | $145 | $164.22 | -66.1% | Sep 24, 2024 |
| UBS | Manav Gupta | $189 | $163.58 | -55.8% | Sep 14, 2024 |
| Wolfe Research | Doug Leggate | $200 | $165.56 | -53.2% | Jul 17, 2024 |
| Jefferies | Lloyd Byrne | $231 | $165.46 | -45.9% | Jul 14, 2024 |
| Wells Fargo | Roger Read | $196 | $164.29 | -54.1% | Jul 12, 2024 |
| Mizuho Securities | Nitin Kumar | $201 | $172.45 | -53.0% | Jun 20, 2024 |
| Piper Sandler | Ryan Todd | $168 | $168.9 | -60.7% | Jun 14, 2024 |
| Raymond James | Justin Jenkins | $230 | $174.66 | -46.2% | May 30, 2024 |
| Piper Sandler | Ryan Todd | $190 | $177.86 | -55.5% | May 14, 2024 |
| Mizuho Securities | Nitin Kumar | $203 | $179.56 | -52.5% | May 13, 2024 |
| Barclays | Theresa Chen | $195 | $182.55 | -54.4% | May 6, 2024 |
| Mizuho Securities | Nitin Kumar | $202 | $212.27 | -52.7% | Apr 12, 2024 |
| Piper Sandler | Ryan Todd | $204 | $216.25 | -52.3% | Apr 5, 2024 |
| Wells Fargo | Roger Read | $227 | $214.96 | -46.9% | Apr 4, 2024 |
| Mizuho Securities | Nitin Kumar | $160 | $128.38 | -62.6% | Mar 10, 2023 |
| UBS | Manav Gupta | $165 | $129.41 | -61.4% | Mar 9, 2023 |
| Cowen & Co. | Analyst unavailable | $143 | $123.85 | -66.5% | Feb 1, 2023 |
| Wells Fargo | Analyst unavailable | $153 | $125.67 | -64.2% | Feb 1, 2023 |
| Raymond James | Analyst unavailable | $165 | $128.52 | -61.4% | Feb 1, 2023 |
| Raymond James | Analyst unavailable | $155 | $122.08 | -63.7% | Jan 13, 2023 |
| Piper Sandler | Analyst unavailable | $143 | $109.75 | -66.5% | Dec 19, 2022 |
| Wells Fargo | Roger Read | $117 | $95.79 | -72.6% | Aug 16, 2022 |
| BMO Capital | Phillip Jungwirth | $135 | $84.48 | -68.4% | Jun 29, 2022 |
| Wells Fargo | Roger Read | $129 | $102.17 | -69.8% | Jun 14, 2022 |
| Credit Suisse | Analyst unavailable | $110 | $93.42 | -74.3% | May 4, 2022 |
| Citigroup | Analyst unavailable | $108 | $84.86 | -74.7% | Apr 26, 2022 |
| Morgan Stanley | Connor Lynagh | $115 | $84.08 | -73.1% | Apr 25, 2022 |
| Wells Fargo | Analyst unavailable | $110 | $90.98 | -74.3% | Apr 21, 2022 |
| Citigroup | Prashant Rao | $85 | $72.81 | -80.1% | Jan 19, 2022 |
| Barclays | Theresa Chen | $80 | $72.16 | -81.3% | Jan 11, 2022 |
| Bank of America Securities | Doug Leggate | $88 | $69.93 | -79.4% | Jan 10, 2022 |
| UBS | Lloyd Byrne | $73 | $63.11 | -82.9% | Nov 17, 2021 |
| Goldman Sachs | Neil Mehta | $73 | $62.66 | -82.9% | Nov 3, 2021 |
| Wolfe Research | Sam Margolin | $68 | $55.29 | -84.1% | May 4, 2021 |
Track every rating change on MPC the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationMarathon Petroleum Corporation (MPC) functions as a prominent integrated energy enterprise, primarily concentrating its downstream operations across the United States. Its business is bifurcated into two main divisions: Refining & Marketing, and Midstream. The Refining & Marketing segment is responsible for processing crude oil and various other raw materials at its refineries, strategically located in the U.S. Gulf Coast, Mid-Continent, and West Coast regions. This division also acquires refined petroleum products and ethanol for subsequent distribution. Key outputs from this segment encompass a diverse array of transportation fuels, including different gasoline blends, heavy fuel oil, and asphalt. Additionally, it manufactures chemicals such as aromatics, propane, propylene, and sulfur.…
Historical context
All MPC earningsEnergy peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| MPLX MPLX Lp | FY2026 Q3 · Calendar Q4 2026 | — | -2.4% | MPLX pairs 5% EBITDA growth with a larger project and divestiture agenda |
| FANG Diamondback Energy, Inc. | FY2026 Q3 · Calendar Q4 2026 | +2.4% | -3.7% | FANG Q3: Permian focus, low reinvestment and recovery initiatives |
| VNOM Viper Energy, Inc. | FY2026 Q3 · Calendar Q4 2026 | +3.9% | -2.6% | VNOM raises FY2026 production outlook after strong Q3 output and acquisitions |
| WMB The Williams Companies, Inc. | FY2026 Q3 · Calendar Q4 2026 | +0.2% | +3.5% | Williams posts record Q3 EBITDA; holds 2026 guidance |
Latest beats and misses
Who reports nextBeat on EPS
- FANGFY2026 Q3 · November 2, 2026+2.4% EPS-3.7% move
- RRXFY2026 Q3 · November 3, 2026+41.1% EPS+11.8% move
- UDRFY2026 Q3 · November 2, 2026+340.8% EPS+0.1% move
- VNOMFY2026 Q3 · November 2, 2026+3.9% EPS-2.6% move
- EQH-PAFY2026 Q3 · November 2, 2026+14.5% EPS— move
- WMBFY2026 Q3 · November 2, 2026+0.2% EPS+3.5% move
Get the MPC recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-11-03T20:07:42.230717+00:00
- FN2 earnings calendar · 2026-11-03T01:23:13.143323+00:00
- Polygon adjusted daily market bars · 2026-11-03T22:00:46.669168+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-11-03T22:00:46.666573+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-11-03. For educational purposes only; not investment advice.